Advertisement
Advertisement

NMTC

NMTC logo

NeuroOne Medical Technologies Corporation Common Stock

3.27
USD
Sponsored
-0.08
-2.39%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

3.20

-0.07
-2.20%

NMTC Earnings Reports

Positive Surprise Ratio

NMTC beat 14 of 18 last estimates.

78%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.60M
/
-$0.22
Implied change from Q2 26 (Revenue/ EPS)
+8.67%
/
-12.00%
Implied change from Q3 25 (Revenue/ EPS)
+53.20%
/
+22.22%

NeuroOne Medical Technologies Corporation Common Stock earnings per share and revenue

On May 12, 2026, NMTC reported earnings of -0.25 USD per share (EPS) for Q2 26, missing the estimate of -0.23 USD, resulting in a -8.13% surprise. Revenue reached 2.39 million, compared to an expected 2.63 million, with a -9.01% difference. The market reacted with a -9.03% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 2.60 million USD, implying an decrease of -12.00% EPS, and increase of 8.67% in Revenue from the last quarter.
FAQ
For Q2 2026, NeuroOne Medical Technologies Corporation Common Stock reported EPS of -$0.25, missing estimates by -8.13%, and revenue of $2.39M, -9.01% below expectations.
The stock price moved down -9.03%, changed from $4.76 before the earnings release to $4.33 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 4 analysts, NeuroOne Medical Technologies Corporation Common Stock is expected to report EPS of -$0.22 and revenue of $2.60M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement